Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 03, 2019
Novartis has entered into an agreement and plan of merger with AveXis to acquire the US-based clinical stage gene therapy company for $218 per share or a total of $8.7 billion in cash.
read more
Wednesday, April 03, 2019
Pii and AST have announced their partnership on the new GENiSYS® R filling machine for syringes, cartridges and vials.
read more
Wednesday, April 03, 2019
Fran Zipp, President and CEO of Lachman Consultants has announced Mary Oates has joined the firm as Vice President of Compliance Services.
read more
UK-based CDMO, Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina.
read more
GenScript® has launched a single-stranded DNA (ssDNA) service.
read more
Particle Testing Authority (PTA) announced the opening of its European laboratory in Munich, Germany.
read more
The FDA posted warning letters to four companies who produce homeopathic drug products for significant violations of CGMP.
read more
Abzena has appointed Dr. Campbell Bunce as Chief Scientific Officer (CSO) and Bo Adair MBA as Senior Vice President Process and Operations.
read more
Puma and Pierre Fabre have entered into an exclusive license agreement under which Pierre Fabre will develop and commercialize NERLYNX® (neratinib) within Europe and part of Africa.
read more
BioProcess Technology Consultants (BPTC) announced the closing of its acquisition by BDO USA, a professional services organization.
read more
Thermo Fisher Scientific and Brammer Bio announced they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately $1.7 billion in cash.
read more
Veeva Systems announced Tom Schwenger will join the company as president and COO in September 2019 to lead strategy, sales, and services.
read more
3P Biopharmaceuticals has signed a collaboration agreement with the Dutch biotech company Xenikos that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®.
read more
Transcenta announced its subsidiary has signed an exclusive agreement with Lilly to license a portfolio of novel biotherapeutics programs for development and commercialization in China.
read more
Merck announced an investment of €150 million in its manufacturing site at Aubonne, Switzerland, to expand manufacturing capacity for its biotech medicines.
read more